<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Sat, 02 May 2026 22:20:19 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/gefitinib/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Tyrosine Kinase Inhibitors Revolutionising Non-Small Cell Lung Cancer Treatment]]></title><description><![CDATA[Tyrosine kinase inhibitors have become a revolutionary approach and drastically changed the landscape of treatment approaches in treating non small cell lung cancer. It enormously improved the quality]]></description><link>http://direct.ecency.com/mrmed/@mrmed/tyrosine-kinase-inhibitors-revolutionising-non</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/tyrosine-kinase-inhibitors-revolutionising-non</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Wed, 17 Jan 2024 07:19:51 GMT</pubDate></item><item><title><![CDATA[EGFR-Tyrosine Kinase Inhibitors (TKIs) in NSCLC]]></title><description><![CDATA[Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKIs) is a group of medicine that plays an important role in treating non-small cell lung cancer (NSCLC). It can be the best replacement]]></description><link>http://direct.ecency.com/mrmed/@mrmed/egfr-tyrosine-kinase-inhibitors-tkis</link><guid isPermaLink="true">http://direct.ecency.com/mrmed/@mrmed/egfr-tyrosine-kinase-inhibitors-tkis</guid><category><![CDATA[mrmed]]></category><dc:creator><![CDATA[mrmed]]></dc:creator><pubDate>Mon, 25 Dec 2023 04:21:45 GMT</pubDate></item></channel></rss>